Read more

July 23, 2021
1 min read
Save

Health care, ophthalmology markets offer ‘favorable environment’ for investment

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

LAS VEGAS — During a presentation at Eyecelerator@ASCRS, Chris Cooley, CFA, managing director of Stephens Inc., said that health care markets are rallying after COVID-19 disruptions.

Chris Cooley

“2020 was unprecedented in all of our lifetimes. But the markets today, with actual all-time highs, present their own unique set of challenges and opportunities,” Cooley said. “If I could impart one thing to you today, it’s that despite the increased incidence of COVID-19 variances and the first real inflationary figures that we have seen in about 15 years, there still exists a favorable environment to invest in growth and innovation.”

Since the beginning of 2020, health care has accounted for 50% of all initial public offerings, Cooley said, explaining that the success of these IPOs is due to “a durable economic business model that has the potential for margin expansion in the long term.”

He attributed the returning success of health care markets to a decades-high spike in consumer confidence as well as growing disposable income resulting from factors such as historically low mortgage rates. He also noted that $79.8 billion in venture capital funding was raised in 2020 compared with $60.1 billion in 2019, with $32.7 billion already raised through the first quarter of 2021.

Within the market landscape, “ophthalmology is known for its innovation,” Cooley said.

“The challenges that we face are not the same as what we saw at the start of 2020, but they are no less relevant or less important,” he said.